Format

Send to

Choose Destination
South Med J. 2003 Jul;96(7):699-701.

Orally disintegrating olanzapine for the treatment of psychotic and behavioral disturbances associated with dementia.

Author information

1
Department of Psychiatry, University of Mississippi School of Medicine, Jackson, MS, USA. roy.reeves@med.va.gov

Abstract

Orally disintegrating olanzapine is a recently marketed form of olanzapine that dissolves rapidly on contact with saliva. We describe six demented patients resistant to treatment with common oral antipsychotic medications who were successfully treated with the formulation. The importance of these case reports is to make physicians aware that orally disintegrating olanzapine may be useful for the management of psychobehavioral disturbances in demented patients who resist or have difficulty taking standard oral medications.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Southern Medical Association
Loading ...
Support Center